ATORVASTATIN RATIOPHARM GMBH

40MG TBL FLM 90

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Resumption of marketing 01.01.2022
Interruption of marketing 10.01.2022 0138125, 0145808, 0148306, 0148308, 0148309, 0200829, 0204690, 0204694, 0225126, 0234341, 0234348, 0243662, 0087018, 0087051
Commercial/marketing reasons 28.2.2022
Resumption of marketing 25.11.2020
Interruption of marketing 26.10.2020 0138125, 0145808, 0148306, 0148309, 0200829, 0204690, 0204694, 0225126, 0226035, 0234341, 0234348, 0087018, 0087051, 0093019, 0093021
Capacity/distribution reasons 21.12.2020
Placing on the market 20.04.2020

All reports are available in the Overview.

Back to list